MBX Biosciences, Inc.
MBX
$8.70
$0.070.81%
| 09/30/2024 | 06/30/2024 | 09/30/2023 | |||
|---|---|---|---|---|---|
| Net Income | -14.41% | -28.53% | -33.58% | ||
| Total Depreciation and Amortization | 19.05% | 31.25% | 2.56% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 25.15% | -55.90% | 603.49% | ||
| Change in Net Operating Assets | 37.25% | 365.21% | 1,656.86% | ||
| Cash from Operations | -10.50% | -23.90% | -4.67% | ||
| Capital Expenditure | 87.39% | -65.57% | 29.03% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -1,254.09% | -147.38% | -192.92% | ||
| Cash from Investing | -1,177.25% | -151.14% | -193.17% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 348,922.00% | -73.54% | -97.32% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -21.31% | -30,083.33% | -- | ||
| Cash from Financing | 13,490.91% | -1,062.30% | 10,703.79% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 625.09% | -567.61% | 218.90% | ||
